A detailed history of Point72 Europe (London) LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 159,953 shares of ANNX stock, worth $825,357. This represents 0.06% of its overall portfolio holdings.

Number of Shares
159,953
Previous 234,592 31.82%
Holding current value
$825,357
Previous $1.15 Million 17.67%
% of portfolio
0.06%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.49 - $7.2 $335,129 - $537,400
-74,639 Reduced 31.82%
159,953 $946,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $1.02 Million - $1.59 Million
234,592 New
234,592 $1.15 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $246M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Point72 Europe (London) LLP Portfolio

Follow Point72 Europe (London) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Europe (London) LLP with notifications on news.